Evidence map›Paper›PMID 38991619›Full record

ArticleCell chemical biology2024

The hydrophobicity of the CARD8 N-terminus tunes inflammasome activation.

Lydia P Tsamouri, Jeffrey C Hsiao, Qinghui Wang, Michael B Geeson, Hsin-Che Huang, Deepika R Nambiar, Mengyang Zou, Daniel P Ball, Ashley J Chui, Daniel A Bachovchin

Abstract read
In one paragraph

Article in Cell chemical biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lydia P TsamouriPharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Jeffrey C HsiaoPharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Qinghui WangChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Michael B GeesonChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Hsin-Che HuangTri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Deepika R NambiarTri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Mengyang ZouBiochemistry, Structural, Cell, Developmental and Molecular Biology Allied Program, Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA.
Daniel P BallChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ashley J ChuiTri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Daniel A BachovchinPharmacology Program of the Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: bachovcd@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced PyroptosisR01AI137168 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Daniel Bachovchin · 2018 to 2026
$4.3M
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid LeukemiaR01CA266478 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Daniel Bachovchin · 2022 to 2026
$3.1M
Redox control of the NLRP1 inflammasomeR01AI163170 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI BACHOVCHIN, DANIEL · 2021 to 2025
$2.6M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA266478NIAID NIH HHS R01 AI137168NIAID NIH HHS R01 AI163170
6 · The paper itself

Abstract

Mounting evidence indicates that proteotoxic stress is a primary activator of the CARD8 inflammasome, but the complete array of signals that control this inflammasome have not yet been established. Notably, we recently discovered that several hydrophobic radical-trapping antioxidants (RTAs), including JSH-23, potentiate CARD8 inflammasome activation through an unknown mechanism. Here, we report that these RTAs directly alkylate several cysteine residues in the N-terminal disordered region of CARD8. These hydrophobic modifications destabilize the repressive CARD8 N-terminal fragment and accelerate its proteasome-mediated degradation, thereby releasing the inflammatory CARD8 C-terminal fragment from autoinhibition. Consistently, we also found that unrelated (non-RTA) hydrophobic electrophiles as well as genetic mutation of the CARD8 cysteine residues to isoleucines similarly potentiate inflammasome activation. Overall, our results not only provide further evidence that protein folding stress is a key CARD8 inflammasome-activating signal, but also indicate that the N-terminal cysteines can play key roles in tuning the response to this stress.

Indexed as

CARD Signaling Adaptor ProteinsHydrophobic and Hydrophilic InteractionsInflammasomesAnimalsAntioxidantsCysteineHEK293 CellsHumansMiceNeoplasm ProteinsAntioxidantsCARD8 protein, humanCARD Signaling Adaptor ProteinsCysteineInflammasomesNeoplasm ProteinsCARD8cysteinesdegradationhydrophobicitinflammasomeproteasomeprotein disorderpyroptosis

Identifiers

PMID38991619
PMCPMC11416329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.